keyboard_arrow_up

A CAGR of 17.6% Projected by latest Report on Cell Expansion Market , The Forecast is to 2021 and the market is expected to reach USD 18.76 Billion By 2021

The global cell expansion market consists of various products used for the mass production of cells. The growth of this market is driven by several factors such as increasing government funding for research, high prevalence of chronic diseases, rising company investments for the development of cell-based products, and growing number of GMP-certified production facilities. High potential growth in emerging markets has opened an array of opportunities for the market. However, the high cost of cell-based research and ethical concerns are hampering the growth of the global market.
The cell expansion market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6%. This market is segmented based on product, cell type, application, end user, and region.

Complete report, on cell expansion market spread across 189 pages, with 168 tables and 48 figures is now available at http://www.rnrmarketresearch.com/cell-expansion-market-by-product-reagent-media-serum-bioreactors-centrifuge-cell-type-human-animal-application-stem-cell-research-regenerative-medicine-clinical-diagnostics-end-user-h-market-report.html

Based on product, the cell expansion market is segmented into consumables and instruments. Consumables include reagents, media and serum, and disposables. Disposables are further classified into tissue culture flasks, bioreactor accessories, and other disposables. The consumables segment is expected to account for the largest share of the market in 2016, due to high prevalence of diseases and increasing funding for cell-based research. The instruments segment comprises cell expansion supporting equipment, bioreactors, and automated cell expansion systems. Cell expansion supporting equipment is segmented into flow cytometers, centrifuges, cell counters, and other supporting equipment. Cell expansion supporting equipment is expected to account for largest share of the instruments market in 2016 owing to technological advancements and new product launches. Bioreactors are further classified into microcarrier bioreactors and perfusion/hollow fiber reactors. Microcarrier bioreactors include microcarrier-based anchorage dependent and suspension-based anchorage independent bioreactors.
Geographically, the cell expansion market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for research in the North American countries.

The major factors contributing to the growth of the cell expansion market include increasing government funding for research, high prevalence of chronic diseases, and growing number of GMP-certified production facilities. Furthermore, increasing R&D spending and new product development activities by companies is another major factor driving the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise product portfolios, developments, and strategies adopted by market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output in order to remain successful in the market.

For a Sample Copy of This Report http://www.rnrmarketresearch.com/contacts/request-sample?rname=235288


The major players in this market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the cell expansion market. The report analyses the cell expansion market byproduct, cell type, application, end user, and region

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the cell expansion market

Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the cell expansion market
Market Development: Comprehensive information about emerging markets. This report analyses the market for various cell expansion market products across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market

Related Report

Single-Cell Analysis Market by Product (Beads, Microplate, Reagents, Flow Cytometer, Microscope, Spectrophotometer), Cell Type (Human, Animal), Technique (NGS, PCR), Application (Cancer, Neurology, NIPD, IVF, CTCs) & End User - Global Forecasts to 2021. Is now available at RnRmarketreserch. As per the report the The global single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion in 2016 at a CAGR of 18.2%. Get more details at  http://www.rnrmarketresearch.com/single-cell-analysis-market-by-product-beads-microplate-reagents-flow-cytometer-microscope-spectrophotometer-cell-type-human-animal-technique-ngs-pcr-application-cancer-neurology-nipd-ivf-ctcs-ts-to-2021-market-report.html